Resumen de acción CL
Colgate-Palmolive Company, junto con sus filiales, fabrica y vende productos de consumo en Estados Unidos y a escala internacional.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 4/6 |
| Crecimiento futuro | 2/6 |
| Resultados anteriores | 4/6 |
| Salud financiera | 4/6 |
| Dividendos | 5/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
Competidores de Colgate-Palmolive Company
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$99.39 |
| Máximo en 52 semanas | US$100.61 |
| Mínimo de 52 semanas | US$67.62 |
| Beta | 0.39 |
| 11 mes Cambio | 2.42% |
| Variación en 3 meses | 9.84% |
| Cambio de 1 año | 31.43% |
| 3Variación en 3 años | 25.02% |
| Variación en 5 años | 39.59% |
| Variación desde la OPV | 10,650.92% |
Noticias y actualizaciones recientes
Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)
Jul 11
Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings
Jul 10Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite
Jun 23Recent updates
Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)
Jul 11Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings
Jul 10Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite
Jun 23Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital
May 21Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report
Apr 30Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends
Nov 06Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Colgate-Palmolive: Dividend King With Limited Growth
Sep 27An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued
Sep 11Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Aug 03Colgate-Palmolive: Challenging Growth Prospects
Jul 10Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48
Jun 27Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48
Jun 13Colgate-Palmolive: The Reasons We Are Becoming More Cautious
Jun 05Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly
Jun 05Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)
May 18Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Feb 23Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)
Feb 05What to expect from Colgate-Palmolive's Q4 2022 Earnings
Jan 26Colgate-Palmolive declares $0.47 dividend
Jan 12Lorrie Norrington named lead independent director of Colgate
Jan 03Colgate-Palmolive (NYSE:CL) Will Be Hoping To Turn Its Returns On Capital Around
Jan 01Rentabilidad de los accionistas
| CL | US Household Products | Mercado US | |
|---|---|---|---|
| 7D | 1.3% | 0.5% | -0.6% |
| 1Y | 31.4% | 7.9% | 17.3% |
Rentabilidad vs. Industria: CL superó a la industria US Household Products, que obtuvo un rendimiento del 12.7% el año pasado.
Rentabilidad vs. Mercado: CL superó al mercado US, que obtuvo un rendimiento del 22.3% el año pasado.
Volatilidad de los precios
| CL volatility | |
|---|---|
| CL Average Weekly Movement | 2.1% |
| Household Products Industry Average Movement | 3.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: CL no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CL (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1806 | 34,000 | Noel Wallace | www.colgatepalmolive.com |
Colgate-Palmolive Company, junto con sus filiales, fabrica y vende productos de consumo en Estados Unidos y a escala internacional. Opera a través de dos segmentos: Cuidado Oral, Personal y del Hogar; y Nutrición de Mascotas. El segmento de Cuidado Oral, Personal y del Hogar ofrece dentífricos, cepillos de dientes, enjuagues bucales, jabones de manos líquidos y en barra, geles de ducha, champús, acondicionadores, desodorantes y antitranspirantes, productos para la salud de la piel, detergentes lavavajillas, acondicionadores de tejidos, limpiadores domésticos y otros artículos relacionados.
Resumen de fundamentos de Colgate-Palmolive Company
| Estadísticas fundamentales de CL | |
|---|---|
| Capitalización bursátil | US$81.21b |
| Beneficios(TTM) | US$2.84b |
| Ingresos (TTM) | US$19.99b |
28.6x
Ratio precio-beneficio (PE)4.1x
Ratio precio-ventas (PS)¿Está CL sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CL | |
|---|---|
| Ingresos | US$19.99b |
| Coste de los ingresos | US$8.06b |
| Beneficio bruto | US$11.93b |
| Otros gastos | US$9.09b |
| Beneficios | US$2.84b |
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 3.48 |
| Margen bruto | 59.70% |
| Margen de beneficio neto | 14.21% |
| Ratio deuda/patrimonio | 1,800.0% |
¿Cómo se ha desempeñado CL a largo plazo?
Ver rendimiento histórico y comparativa